Vitamin E binding protein Afamin protects neuronal cells in vitro

Journal of Neural Transmission, Supplement

Volumn , Issue 62, 2002, Pages 337-345

  Heiser, M ^a,c   Hutter Paier, B ^a   Jerkovic, L ^b   Pfragner, R ^c   Windisch, M ^a   Becker Andre M ^b   Dieplinger, H ^b,d,e  

^a JSW Life Sciences GmbH   (Austria)

^b Vitateq Biotechnology GmbH   (Austria)

^c UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITY OF INNSBRUCK   (Austria)

^e Inst of Med Biol and Hum Genet   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AFAMIN; ALPHA TOCOPHEROL; BINDING PROTEIN; GLYCOPROTEIN; MANGANESE SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; AFM PROTEIN, HUMAN; ANTIOXIDANT; CARRIER PROTEIN; NEUROPROTECTIVE AGENT; SERUM ALBUMIN;

ALZHEIMER DISEASE; APOPTOSIS; CALCIUM HOMEOSTASIS; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CONFERENCE PAPER; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; LIPID PEROXIDATION; NEUROPROTECTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TRANSPORT KINETICS; ANIMAL; ARTICLE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; IN VITRO STUDY; METABOLISM; NERVE CELL;

ANIMALS; ANTIOXIDANTS; CARRIER PROTEINS; CELL SURVIVAL; CELLS, CULTURED; GLYCOPROTEINS; HUMANS; NEURONS; NEUROPROTECTIVE AGENTS; SERUM ALBUMIN; VITAMIN E;

EID: 0036045110     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6139-5_32     Document Type: Conference Paper

References (32)

1. Aigner A, Wolf S, Gassen HG (1997) Transport und Entgiftung: Ansätze und Perspektiven für die Erforschung der Blut-Hirn-Schranke. Angew Chem 109: 25-42
2. Atabay C, Cagnoli CM, Kharlamov E, Ikonomovic MD, Manev H (1996) Removal of serum from primary cultures of cerebellar granule neurons induces oxidative stress and DNA fragmentation: protection with antioxidants and glutamate receptor antagonists. J Neurosci Res 43: 465-475
3. Behl C (1999) Vitamin E and other antioxidants in neuroprotection. Int J Vitam Nutr Res 69(3): 213-219
4. Behl C, Moosmann B (2000) Estrogen and other antioxidants in neuroprotection: implications for Alzheimer's disease. In: Poli G, Cadenas E, Packer L (eds) Free radicals in brain pathophysiology, 1st edn. Marcel Dekker, New York Basel, p 467
5. Brera B, Serrano A, Ceballos ML (2000) β-amyloid peptides are cytotoxic to astrocytes in culture: a role for oxidative stress. Neurobiol Dis 7: 395-405
6. Christen Y (2000) Oxidative stress and Alzheimer's disease. Am J Clin Nutr 71(2): 621-629
7. Contestabile A (2001) Antioxidant strategies for neurodegenerative diseases. Exp Opin Ther Patents 11(4): 573-585
8. Dutta-Roy AK (1999) Molecular mechanism of cellular uptake and intracellular translocation of α-tocopherol: role of tocopherol-binding proteins. Food Chem Toxicol 37(9-10): 967-971
9. Gutmann B, Hutter-Paier B, Skofitsch G, Windisch M, Gmeinbauer R (2002) In vitro models of brain ischemia: the peptidergic drug Cerebrolysin® protects cultured chick cortical neurons from cell death. Neurotox Res 4: 59-65
10. Herrera E, Barbas C (2001) Vitamin E: action, metabolism and perspectives. J Physiol Biochem 57(2): 43-56
11. Honig LS, Mayeux R (2001) Natural history of Alzheimer's disease. Aging Clin Exp Res 13: 171-182
12. Huang HM, Ou HC, Hsieh SJ (2000) Antioxidants prevent amyloid peptide-induced apoptosis and alteration of calcium homeostasis in cultured cortical neurons. Life Sci 66(19): 1879-1892
13. Hutter-Paier B, Steiner E, Windisch M (1998) Cerebrolysin® protects isolated cortical neurons from neurodegeneration after brief histotoxic hypoxia. J Neural Transm 53: 351-361
14. Jerkovic L (1997) Biochemical characterization of a vitamin E-binding protein from human plasma. Thesis, University of Innsbruck
15. Jiménez-Jiménez FJ, Bustos F, Molina JA, Benito-Leén J, Tallón-Barranco, Gasalla T, Arenas J, Enriquez-de-Salamanca R (1997) Cerebrospinal fluid levels of α-tocopherol (vitamin E) in Alzheimer's disease. J Neural Transm 104(6-7): 703-710
16. Lichenstein HS, Lyons DE, Wurfel MM, Johnson DA, McGinley MD, Leidli JC, Trollinger DB, Mayer JP, Wright SD, Zukowski MM (1994) Afamin is a new member of the albumin, α-fetoprotein, and vitamin D-binding protein gene family. J Biol Chem 269(27): 18149-18154
17. Massoud F, Schittini M, Sano M (2000) Vitamin E and other antioxidant treatments for the neurobehavioral aspects of Alzheimer's disease and other neurodegenerative diseases. In: Poli G, Cadenas E, Packer L (eds) Free radicals in brain pathophysiology, 1st edn. Marcel Dekker, New York Basel, p 501
18. Mattson MP (2000a) Free radical-mediated disruption of cellular ion homeostasis, mitochondrial dysfunction, and neuronal degeneration in sporadic and inherited Alzheimer's disease. In: Poli G, Cadenas E, Packer L (eds) Free radicals in brain pathophysiology, 1st edn. Marcel Dekker, New York Basel, p 323
19. Mattson MP (2000b) Emerging neuroprotective strategies for Alzheimer's disease: dietary restriction, telomerase activation, and stem cell therapy. Exp Gerontol 35: 489-502
20. Reinprecht K, Hutter-Paier B, Crailsheim K, Windisch M (1998) Influence of BDNF and FCS on viability and programmed cell death (PCD) of developing cortical chicken neurons in vitro. J Neural Transm 53: 373-384
21. Ricart KC, Fiszman ML (2001) Hydrogen peroxide-induced neurotoxicity in cultured cortical cells grown in serum-free and serum-containing media. Neurochem Res 26(7): 801-808
22. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ (1997) A controlled trial of Selegiline, α-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 336: 1216-1222
23. Selkoe DJ (2001) Alzheimer's disease: genes, proteins and therapy. Physiol Rev 81(2): 741-766
24. Smith MA, Perry G (2000) Molecular and cellular aspects of oxidative damage in Alzheimer's disease. In: Poli G, Cadenas E, Packer L (eds) Free radicals in brain pathophysiology, 1st edn. Marcel Dekker, New York Basel, p 313
25. Tabet N, Birks J, Grimley EJ (2000) Vitamin E for Alzheimer's disease. Cochrane Database Syst Rev 4: CD002854
26. Thal LJ (2000) Trials to slow progression and prevent disease onset. J Neural Transm 59: 243-249
27. Traber MG, Sies H (1996) Vitamin E in humans: demand and delivery. Annu Rev Nutr 16: 321-347
28. Tyas SL, Manfreda J, Strain LA, Montgomery PR (2001) Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada. Int J Epidemiol 30: 590-597
29. Varadarajan S, Yatin S, Aksenova M, Butterfield DA (2000) Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 130: 184-208
30. Vögele (1999) Biochemical characterization of the vitamin E-binding properties of Afamin. Thesis, University of Innsbruck
31. Wronski R, Kronawetter S, Hutter-Paier B, Crailsheim K, Windisch M (2000) A brain derived peptide preparation reduces the translation dependent loss of a cytoskeletal protein in primary cultured chicken neurons. J Neural Transm 59: 263-272
32. Zimmer S, Stocker A, Sarbolouki MN, Spycher SE, Sassoon J, Azzi A (2000) A novel human tocopherol-associated protein: cloning, expression and characterization. J Biol Chem 275(33): 25672-25680